Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022532293> ?p ?o ?g. }
- W2022532293 endingPage "60" @default.
- W2022532293 startingPage "51" @default.
- W2022532293 abstract "ObjectiveDendritic cells (DCs) play a pivotal role in the induction of immunity in response to pathogenic challenge or vaccination. As such, the fms-like tyrosine kinase 3-ligand (Flt-3L) has been used to increase DC populations in vivo, with contrasting outcomes, which include an increase in immunity, tolerance induction, or expansion of regulatory cells. This study examines the adjuvant role that human Flt-3L (hFL) administration has in generating immune responses upon immunization with a poorly immunogenic and soluble protein antigen.Materials and MethodsMice were immunized with the nominal antigen, ovalbumin, alone or with antigen emulsified in complete Freund's adjuvant (CFA), with or without prior hFL-mediated expansion of DC subsets. The maturation of DC subsets and activation status of antigen-specific T cells were analyzed by flow cytometry, with effector function assessed in cytolytic T-lymphocyte assays.ResultshFL treatment expanded both conventional DC and plasmacytoid DC in vivo, resulting in increased antigen presentation by both direct and cross-presentation pathways. However, it was only in the context of CFA that antigen immunization could mature DCs and subsequently fully activate antigen-specific T cells with enhanced cytolytic activity.ConclusionsOur studies reveal that hFL essentially acts as a coadjuvant, as hFL augments the size of an immune response but requires further adjuvant activation to alter the quality of the response. Dendritic cells (DCs) play a pivotal role in the induction of immunity in response to pathogenic challenge or vaccination. As such, the fms-like tyrosine kinase 3-ligand (Flt-3L) has been used to increase DC populations in vivo, with contrasting outcomes, which include an increase in immunity, tolerance induction, or expansion of regulatory cells. This study examines the adjuvant role that human Flt-3L (hFL) administration has in generating immune responses upon immunization with a poorly immunogenic and soluble protein antigen. Mice were immunized with the nominal antigen, ovalbumin, alone or with antigen emulsified in complete Freund's adjuvant (CFA), with or without prior hFL-mediated expansion of DC subsets. The maturation of DC subsets and activation status of antigen-specific T cells were analyzed by flow cytometry, with effector function assessed in cytolytic T-lymphocyte assays. hFL treatment expanded both conventional DC and plasmacytoid DC in vivo, resulting in increased antigen presentation by both direct and cross-presentation pathways. However, it was only in the context of CFA that antigen immunization could mature DCs and subsequently fully activate antigen-specific T cells with enhanced cytolytic activity. Our studies reveal that hFL essentially acts as a coadjuvant, as hFL augments the size of an immune response but requires further adjuvant activation to alter the quality of the response." @default.
- W2022532293 created "2016-06-24" @default.
- W2022532293 creator A5000880643 @default.
- W2022532293 creator A5002182403 @default.
- W2022532293 creator A5021075431 @default.
- W2022532293 creator A5030331024 @default.
- W2022532293 creator A5078118457 @default.
- W2022532293 date "2008-01-01" @default.
- W2022532293 modified "2023-10-17" @default.
- W2022532293 title "Human Flt-3 ligand-mobilized dendritic cells require additional activation to drive effective immune responses" @default.
- W2022532293 cites W134922517 @default.
- W2022532293 cites W1566106175 @default.
- W2022532293 cites W1584203472 @default.
- W2022532293 cites W1858218633 @default.
- W2022532293 cites W1959677146 @default.
- W2022532293 cites W1975773646 @default.
- W2022532293 cites W1990417936 @default.
- W2022532293 cites W1995283397 @default.
- W2022532293 cites W1997276741 @default.
- W2022532293 cites W2000686840 @default.
- W2022532293 cites W2002018327 @default.
- W2022532293 cites W2003656264 @default.
- W2022532293 cites W2006772331 @default.
- W2022532293 cites W2008354811 @default.
- W2022532293 cites W2012148175 @default.
- W2022532293 cites W2022262230 @default.
- W2022532293 cites W2022890571 @default.
- W2022532293 cites W2025350367 @default.
- W2022532293 cites W2048143404 @default.
- W2022532293 cites W2049468976 @default.
- W2022532293 cites W2054678965 @default.
- W2022532293 cites W2064877723 @default.
- W2022532293 cites W2071969437 @default.
- W2022532293 cites W2074150439 @default.
- W2022532293 cites W2084390253 @default.
- W2022532293 cites W2108765339 @default.
- W2022532293 cites W2111220263 @default.
- W2022532293 cites W2111799518 @default.
- W2022532293 cites W2122206758 @default.
- W2022532293 cites W2133449490 @default.
- W2022532293 cites W2140516659 @default.
- W2022532293 cites W2146356912 @default.
- W2022532293 cites W2152627678 @default.
- W2022532293 cites W2156152783 @default.
- W2022532293 cites W2156831625 @default.
- W2022532293 cites W2161472648 @default.
- W2022532293 cites W2170933182 @default.
- W2022532293 cites W4240786696 @default.
- W2022532293 doi "https://doi.org/10.1016/j.exphem.2007.08.024" @default.
- W2022532293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17949888" @default.
- W2022532293 hasPublicationYear "2008" @default.
- W2022532293 type Work @default.
- W2022532293 sameAs 2022532293 @default.
- W2022532293 citedByCount "19" @default.
- W2022532293 countsByYear W20225322932015 @default.
- W2022532293 countsByYear W20225322932018 @default.
- W2022532293 countsByYear W20225322932019 @default.
- W2022532293 countsByYear W20225322932021 @default.
- W2022532293 countsByYear W20225322932023 @default.
- W2022532293 crossrefType "journal-article" @default.
- W2022532293 hasAuthorship W2022532293A5000880643 @default.
- W2022532293 hasAuthorship W2022532293A5002182403 @default.
- W2022532293 hasAuthorship W2022532293A5021075431 @default.
- W2022532293 hasAuthorship W2022532293A5030331024 @default.
- W2022532293 hasAuthorship W2022532293A5078118457 @default.
- W2022532293 hasBestOaLocation W20225322931 @default.
- W2022532293 hasConcept C147483822 @default.
- W2022532293 hasConcept C193419808 @default.
- W2022532293 hasConcept C203014093 @default.
- W2022532293 hasConcept C2776090121 @default.
- W2022532293 hasConcept C2777863537 @default.
- W2022532293 hasConcept C2778170410 @default.
- W2022532293 hasConcept C67662055 @default.
- W2022532293 hasConcept C83464605 @default.
- W2022532293 hasConcept C86803240 @default.
- W2022532293 hasConcept C8891405 @default.
- W2022532293 hasConcept C95444343 @default.
- W2022532293 hasConceptScore W2022532293C147483822 @default.
- W2022532293 hasConceptScore W2022532293C193419808 @default.
- W2022532293 hasConceptScore W2022532293C203014093 @default.
- W2022532293 hasConceptScore W2022532293C2776090121 @default.
- W2022532293 hasConceptScore W2022532293C2777863537 @default.
- W2022532293 hasConceptScore W2022532293C2778170410 @default.
- W2022532293 hasConceptScore W2022532293C67662055 @default.
- W2022532293 hasConceptScore W2022532293C83464605 @default.
- W2022532293 hasConceptScore W2022532293C86803240 @default.
- W2022532293 hasConceptScore W2022532293C8891405 @default.
- W2022532293 hasConceptScore W2022532293C95444343 @default.
- W2022532293 hasIssue "1" @default.
- W2022532293 hasLocation W20225322931 @default.
- W2022532293 hasLocation W20225322932 @default.
- W2022532293 hasOpenAccess W2022532293 @default.
- W2022532293 hasPrimaryLocation W20225322931 @default.
- W2022532293 hasRelatedWork W1432214059 @default.
- W2022532293 hasRelatedWork W1500819482 @default.
- W2022532293 hasRelatedWork W2067868325 @default.
- W2022532293 hasRelatedWork W2071797190 @default.
- W2022532293 hasRelatedWork W2113289699 @default.